Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of amino acid metabolism (HP:0004337)help
Parent Node:
expand
Abnormal circulating pyruvate family amino acid concentration (HP:0010915)help
..Starting node
..expand
Abnormal circulating alanine concentration (HP:0010916)help
Term ID: 10916
Name: Abnormal circulating alanine concentration
Synonym: Abnormality of alanine metabolism
Definition: An abnormality of an alanine metabolic process.
Comments:
Reference: HP:0010916
Genes and Diseases:
 
       Child Nodes:
........expandHyperalaninemia (HP:0003348) help

 Sister Nodes: 
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0010916HP:0010916Abnormal circulating alanine concentration0ALDH4A1 CL E G H8659406ORPHA:79101Hyperprolinemia type 274
HP:0010916HP:0010916Abnormal circulating alanine concentration0ATP5F1A CL E G H498823OMIM:616045Combined oxidative phosphorylation deficiency 22
HP:0010916HP:0010916Abnormal circulating alanine concentration0ATP6 CL E G H45087414ORPHA:255210Mitochondrial DNA-associated Leigh syndrome
HP:0010916HP:0010916Abnormal circulating alanine concentration0CA5A CL E G H7631377OMIM:615751Hyperammonemia due to carbonic anhydrase VA deficiency10
HP:0010916HP:0010916Abnormal circulating alanine concentration0COQ9 CL E G H5701725302OMIM:614654Coenzyme Q10 deficiency, primary, 544
HP:0010916HP:0010916Abnormal circulating alanine concentration0COX10 CL E G H13522260OMIM:619046MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3; MC4DN382
HP:0010916HP:0010916Abnormal circulating alanine concentration0COX16 CL E G H5124120213OMIM:619355MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22; MC4DN22
HP:0010916HP:0010916Abnormal circulating alanine concentration0COX5A CL E G H93772267OMIM:619064MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 20; MC4DN20
HP:0010916HP:0010916Abnormal circulating alanine concentration0COX6B1 CL E G H13402280OMIM:619051MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7; MC4DN710
HP:0010916HP:0010916Abnormal circulating alanine concentration0COX8A CL E G H13512294OMIM:619059MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15; MC4DN151
HP:0010916HP:0010916Abnormal circulating alanine concentration0DNM1L CL E G H100592973OMIM:614388Encephalopathy due to defective mitochondrial and peroxisomal fission 194
HP:0010916HP:0010916Abnormal circulating alanine concentration0DTYMK CL E G H18413061OMIM:619847
HP:0010916HP:0010916Abnormal circulating alanine concentration0FBP1 CL E G H22033606ORPHA:348Fructose-1,6-bisphosphatase deficiency64
HP:0010916HP:0010916Abnormal circulating alanine concentration0FBXL4 CL E G H2623513601OMIM:615471Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)384
HP:0010916HP:0010916Abnormal circulating alanine concentration0FOCAD CL E G H5491423377OMIM:6199913
HP:0010916HP:0010916Abnormal circulating alanine concentration0KARS1 CL E G H37356215OMIM:619147LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH OR WITHOUT DEAFNESS; LEPID
HP:0010916HP:0010916Abnormal circulating alanine concentration0LIG3 CL E G H39806600ORPHA:298Mitochondrial neurogastrointestinal encephalomyopathy1
HP:0010916HP:0010916Abnormal circulating alanine concentration0LIPT2 CL E G H38778737216OMIM:617668Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities2
HP:0010916HP:0010916Abnormal circulating alanine concentration0LYRM7 CL E G H9062428072OMIM:615838Mitochondrial complex III deficiency, nuclear type 810
HP:0010916HP:0010916Abnormal circulating alanine concentration0MICOS13 CL E G H12598833702OMIM:618329COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37
HP:0010916HP:0010916Abnormal circulating alanine concentration0MIPEP CL E G H42857104OMIM:617228Combined oxidative phosphorylation deficiency 317
HP:0010916HP:0010916Abnormal circulating alanine concentration0MRPL3 CL E G H1122210379OMIM:614582COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD913
HP:0010916HP:0010916Abnormal circulating alanine concentration0MRPS14 CL E G H6393114049OMIM:618378Combined oxidative phosphorylation deficiency 38
HP:0010916HP:0010916Abnormal circulating alanine concentration0MRPS2 CL E G H5111614495OMIM:617950Combined oxidative phosphorylation deficiency 36
HP:0010916HP:0010916Abnormal circulating alanine concentration0MTO1 CL E G H2582119261OMIM:614702Combined oxidative phosphorylation deficiency 1039
HP:0010916HP:0010916Abnormal circulating alanine concentration0NAGS CL E G H16241717996ORPHA:927Hyperammonemia due to N-acetylglutamate synthase deficiency36
HP:0010916HP:0010916Abnormal circulating alanine concentration0ND1 CL E G H45357455ORPHA:255210Mitochondrial DNA-associated Leigh syndrome
HP:0010916HP:0010916Abnormal circulating alanine concentration0ND2 CL E G H45367456ORPHA:255210Mitochondrial DNA-associated Leigh syndrome
HP:0010916HP:0010916Abnormal circulating alanine concentration0ND3 CL E G H45377458ORPHA:255210Mitochondrial DNA-associated Leigh syndrome
HP:0010916HP:0010916Abnormal circulating alanine concentration0ND4 CL E G H45387459ORPHA:255210Mitochondrial DNA-associated Leigh syndrome
HP:0010916HP:0010916Abnormal circulating alanine concentration0ND5 CL E G H45407461ORPHA:255210Mitochondrial DNA-associated Leigh syndrome
HP:0010916HP:0010916Abnormal circulating alanine concentration0ND6 CL E G H45417462ORPHA:255210Mitochondrial DNA-associated Leigh syndrome
HP:0010916HP:0010916Abnormal circulating alanine concentration0NDUFA13 CL E G H5107917194OMIM:618249Mitochondrial complex I deficiency, nuclear type 283
HP:0010916HP:0010916Abnormal circulating alanine concentration0NDUFB10 CL E G H47167696OMIM:619003MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 35; MC1DN35
HP:0010916HP:0010916Abnormal circulating alanine concentration0NDUFC2 CL E G H47187706OMIM:619170MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 36; MC1DN36
HP:0010916HP:0010916Abnormal circulating alanine concentration0NDUFS4 CL E G H47247711OMIM:252010Mitochondrial complex I deficiency, nuclear type 127
HP:0010916HP:0010916Abnormal circulating alanine concentration0NFS1 CL E G H905415910OMIM:619386COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52; COXPD525
HP:0010916HP:0010916Abnormal circulating alanine concentration0NGLY1 CL E G H5576817646OMIM:615273Congenital disorder of deglycosylation32
HP:0010916HP:0010916Abnormal circulating alanine concentration0PC CL E G H50918636OMIM:266150Pyruvate carboxylase deficiency118
HP:0010916HP:0010916Abnormal circulating alanine concentration0PDHA1 CL E G H51608806OMIM:312170Pyruvate dehydrogenase e1-alpha deficiency88
HP:0010916HP:0010916Abnormal circulating alanine concentration0PDHX CL E G H805021350OMIM:245349Pyruvate dehydrogenase e3-binding protein deficiency98
HP:0010916HP:0010916Abnormal circulating alanine concentration0PDP1 CL E G H547049279ORPHA:79246Pyruvate dehydrogenase phosphatase deficiency52
HP:0010916HP:0010916Abnormal circulating alanine concentration0PNPLA8 CL E G H5064028900OMIM:251950Mitochondrial myopathy with lactic acidosis3
HP:0010916HP:0010916Abnormal circulating alanine concentration0POLG CL E G H54289179ORPHA:298Mitochondrial neurogastrointestinal encephalomyopathy464
HP:0010916HP:0010916Abnormal circulating alanine concentration0RRM2B CL E G H5048417296ORPHA:298Mitochondrial neurogastrointestinal encephalomyopathy125
HP:0010916HP:0010916Abnormal circulating alanine concentration0SCO1 CL E G H634110603OMIM:619048MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4; MC4DN446
HP:0010916HP:0010916Abnormal circulating alanine concentration0SLC25A13 CL E G H1016510983ORPHA:247598Neonatal intrahepatic cholestasis due to citrin deficiencyHP:0040282 - Frequent82
HP:0010916HP:0010916Abnormal circulating alanine concentration0SLC25A4 CL E G H29110990OMIM:615418Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type)68
HP:0010916HP:0010916Abnormal circulating alanine concentration0SLC7A7 CL E G H905611065ORPHA:470Lysinuric protein intolerance104
HP:0010916HP:0010916Abnormal circulating alanine concentration0TARS2 CL E G H8022230740OMIM:615918Combined oxidative phosphorylation deficiency 2128
HP:0010916HP:0010916Abnormal circulating alanine concentration0TMEM126B CL E G H5586330883OMIM:618250Mitochondrial complex I deficiency, nuclear type 294
HP:0010916HP:0010916Abnormal circulating alanine concentration0TMEM70 CL E G H5496826050OMIM:614052Mitochondrial complex V (atp synthase) deficiency, nuclear type 263
HP:0010916HP:0010916Abnormal circulating alanine concentration0TRMT10C CL E G H5493126022OMIM:616974Combined oxidative phosphorylation deficiency 303
HP:0010916HP:0010916Abnormal circulating alanine concentration0TRNK CL E G H45667489ORPHA:255210Mitochondrial DNA-associated Leigh syndrome
HP:0010916HP:0010916Abnormal circulating alanine concentration0TRNL1 CL E G H45677490ORPHA:255210Mitochondrial DNA-associated Leigh syndrome
HP:0010916HP:0010916Abnormal circulating alanine concentration0TRNV CL E G H45777500ORPHA:255210Mitochondrial DNA-associated Leigh syndrome
HP:0010916HP:0010916Abnormal circulating alanine concentration0TRNW CL E G H45787501ORPHA:255210Mitochondrial DNA-associated Leigh syndrome
HP:0010916HP:0010916Abnormal circulating alanine concentration0TYMP CL E G H18903148ORPHA:298Mitochondrial neurogastrointestinal encephalomyopathy138
HP:0010916HP:0010916Abnormal circulating alanine concentration0UQCRC2 CL E G H738512586OMIM:615160Mitochondrial complex III deficiency, nuclear type 517
HP:0010916HP:0010916Abnormal circulating alanine concentration0VARS2 CL E G H5717621642OMIM:615917Combined oxidative phosphorylation deficiency 2056
HP:0010916HP:0500154Hypoalaninemia1 CL E G H
HP:0010916HP:0003348Hyperalaninemia1ALDH4A1 CL E G H8659406ORPHA:79101Hyperprolinemia type 2HP:0040282 - Frequent74
HP:0010916HP:0003348Hyperalaninemia1ATP5F1A CL E G H498823OMIM:616045Combined oxidative phosphorylation deficiency 22.
HP:0010916HP:0003348Hyperalaninemia1ATP6 CL E G H45087414ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040283 - Occasional
HP:0010916HP:0003348Hyperalaninemia1CA5A CL E G H7631377OMIM:615751Hyperammonemia due to carbonic anhydrase VA deficiency.10
HP:0010916HP:0003348Hyperalaninemia1COQ9 CL E G H5701725302OMIM:614654Coenzyme Q10 deficiency, primary, 5.44
HP:0010916HP:0003348Hyperalaninemia1COX10 CL E G H13522260OMIM:619046MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3; MC4DN382
HP:0010916HP:0003348Hyperalaninemia1COX16 CL E G H5124120213OMIM:619355MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22; MC4DN22
HP:0010916HP:0003348Hyperalaninemia1COX5A CL E G H93772267OMIM:619064MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 20; MC4DN20
HP:0010916HP:0003348Hyperalaninemia1COX6B1 CL E G H13402280OMIM:619051MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7; MC4DN710
HP:0010916HP:0003348Hyperalaninemia1COX8A CL E G H13512294OMIM:619059MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15; MC4DN151
HP:0010916HP:0003348Hyperalaninemia1DNM1L CL E G H100592973OMIM:614388Encephalopathy due to defective mitochondrial and peroxisomal fission 194
HP:0010916HP:0003348Hyperalaninemia1DTYMK CL E G H18413061OMIM:619847
HP:0010916HP:0003348Hyperalaninemia1FBP1 CL E G H22033606ORPHA:348Fructose-1,6-bisphosphatase deficiencyHP:0040284 - Very rare64
HP:0010916HP:0003348Hyperalaninemia1FBXL4 CL E G H2623513601OMIM:615471Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type).384
HP:0010916HP:0003348Hyperalaninemia1FOCAD CL E G H5491423377OMIM:6199913
HP:0010916HP:0003348Hyperalaninemia1KARS1 CL E G H37356215OMIM:619147LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH OR WITHOUT DEAFNESS; LEPID
HP:0010916HP:0003348Hyperalaninemia1LIG3 CL E G H39806600ORPHA:298Mitochondrial neurogastrointestinal encephalomyopathyHP:0040282 - Frequent1
HP:0010916HP:0003348Hyperalaninemia1LIPT2 CL E G H38778737216OMIM:617668Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities.2
HP:0010916HP:0003348Hyperalaninemia1LYRM7 CL E G H9062428072OMIM:615838Mitochondrial complex III deficiency, nuclear type 810
HP:0010916HP:0003348Hyperalaninemia1MICOS13 CL E G H12598833702OMIM:618329COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37
HP:0010916HP:0003348Hyperalaninemia1MIPEP CL E G H42857104OMIM:617228Combined oxidative phosphorylation deficiency 31.7
HP:0010916HP:0003348Hyperalaninemia1MRPL3 CL E G H1122210379OMIM:614582COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD913
HP:0010916HP:0003348Hyperalaninemia1MRPS14 CL E G H6393114049OMIM:618378Combined oxidative phosphorylation deficiency 38
HP:0010916HP:0003348Hyperalaninemia1MRPS2 CL E G H5111614495OMIM:617950Combined oxidative phosphorylation deficiency 36
HP:0010916HP:0003348Hyperalaninemia1MTO1 CL E G H2582119261OMIM:614702Combined oxidative phosphorylation deficiency 10HP:0040283 - Occasional39
HP:0010916HP:0003348Hyperalaninemia1NAGS CL E G H16241717996ORPHA:927Hyperammonemia due to N-acetylglutamate synthase deficiencyHP:0040283 - Occasional36
HP:0010916HP:0003348Hyperalaninemia1ND1 CL E G H45357455ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040283 - Occasional
HP:0010916HP:0003348Hyperalaninemia1ND2 CL E G H45367456ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040283 - Occasional
HP:0010916HP:0003348Hyperalaninemia1ND3 CL E G H45377458ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040283 - Occasional
HP:0010916HP:0003348Hyperalaninemia1ND4 CL E G H45387459ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040283 - Occasional
HP:0010916HP:0003348Hyperalaninemia1ND5 CL E G H45407461ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040283 - Occasional
HP:0010916HP:0003348Hyperalaninemia1ND6 CL E G H45417462ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040283 - Occasional
HP:0010916HP:0003348Hyperalaninemia1NDUFA13 CL E G H5107917194OMIM:618249Mitochondrial complex I deficiency, nuclear type 28.3
HP:0010916HP:0003348Hyperalaninemia1NDUFB10 CL E G H47167696OMIM:619003MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 35; MC1DN35
HP:0010916HP:0003348Hyperalaninemia1NDUFC2 CL E G H47187706OMIM:619170MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 36; MC1DN36
HP:0010916HP:0003348Hyperalaninemia1NDUFS4 CL E G H47247711OMIM:252010Mitochondrial complex I deficiency, nuclear type 127
HP:0010916HP:0003348Hyperalaninemia1NFS1 CL E G H905415910OMIM:619386COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52; COXPD525
HP:0010916HP:0003348Hyperalaninemia1NGLY1 CL E G H5576817646OMIM:615273Congenital disorder of deglycosylation32
HP:0010916HP:0003348Hyperalaninemia1PC CL E G H50918636OMIM:266150Pyruvate carboxylase deficiency.118
HP:0010916HP:0003348Hyperalaninemia1PDHA1 CL E G H51608806OMIM:312170Pyruvate dehydrogenase e1-alpha deficiency.88
HP:0010916HP:0003348Hyperalaninemia1PDHX CL E G H805021350OMIM:245349Pyruvate dehydrogenase e3-binding protein deficiency.98
HP:0010916HP:0003348Hyperalaninemia1PDP1 CL E G H547049279ORPHA:79246Pyruvate dehydrogenase phosphatase deficiencyHP:0040282 - Frequent52
HP:0010916HP:0003348Hyperalaninemia1PNPLA8 CL E G H5064028900OMIM:251950Mitochondrial myopathy with lactic acidosis.3
HP:0010916HP:0003348Hyperalaninemia1POLG CL E G H54289179ORPHA:298Mitochondrial neurogastrointestinal encephalomyopathyHP:0040282 - Frequent464
HP:0010916HP:0003348Hyperalaninemia1RRM2B CL E G H5048417296ORPHA:298Mitochondrial neurogastrointestinal encephalomyopathyHP:0040282 - Frequent125
HP:0010916HP:0003348Hyperalaninemia1SCO1 CL E G H634110603OMIM:619048MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4; MC4DN446
HP:0010916HP:0003348Hyperalaninemia1SLC25A4 CL E G H29110990OMIM:615418Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type)68
HP:0010916HP:0003348Hyperalaninemia1SLC7A7 CL E G H905611065ORPHA:470Lysinuric protein intoleranceHP:0040282 - Frequent104
HP:0010916HP:0003348Hyperalaninemia1TARS2 CL E G H8022230740OMIM:615918Combined oxidative phosphorylation deficiency 2128
HP:0010916HP:0003348Hyperalaninemia1TMEM126B CL E G H5586330883OMIM:618250Mitochondrial complex I deficiency, nuclear type 29.4
HP:0010916HP:0003348Hyperalaninemia1TMEM70 CL E G H5496826050OMIM:614052Mitochondrial complex V (atp synthase) deficiency, nuclear type 2.63
HP:0010916HP:0003348Hyperalaninemia1TRMT10C CL E G H5493126022OMIM:616974Combined oxidative phosphorylation deficiency 30.3
HP:0010916HP:0003348Hyperalaninemia1TRNK CL E G H45667489ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040283 - Occasional
HP:0010916HP:0003348Hyperalaninemia1TRNL1 CL E G H45677490ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040283 - Occasional
HP:0010916HP:0003348Hyperalaninemia1TRNV CL E G H45777500ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040283 - Occasional
HP:0010916HP:0003348Hyperalaninemia1TRNW CL E G H45787501ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040283 - Occasional
HP:0010916HP:0003348Hyperalaninemia1TYMP CL E G H18903148ORPHA:298Mitochondrial neurogastrointestinal encephalomyopathyHP:0040282 - Frequent138
HP:0010916HP:0003348Hyperalaninemia1UQCRC2 CL E G H738512586OMIM:615160Mitochondrial complex III deficiency, nuclear type 517
HP:0010916HP:0003348Hyperalaninemia1VARS2 CL E G H5717621642OMIM:615917Combined oxidative phosphorylation deficiency 2056


Genes (60) :ALDH4A1 ATP5F1A ATP6 CA5A COQ9 COX10 COX16 COX5A COX6B1 COX8A DNM1L DTYMK FBP1 FBXL4 FOCAD KARS1 LIG3 LIPT2 LYRM7 MICOS13 MIPEP MRPL3 MRPS14 MRPS2 MTO1 NAGS ND1 ND2 ND3 ND4 ND5 ND6 NDUFA13 NDUFB10 NDUFC2 NDUFS4 NFS1 NGLY1 PC PDHA1 PDHX PDP1 PNPLA8 POLG RRM2B SCO1 SLC25A13 SLC25A4 SLC7A7 TARS2 TMEM126B TMEM70 TRMT10C TRNK TRNL1 TRNV TRNW TYMP UQCRC2 VARS2

Diseases (47) :ORPHA:79101 OMIM:616045 ORPHA:255210 OMIM:615751 OMIM:614654 OMIM:619046 OMIM:619355 OMIM:619064 OMIM:619051 OMIM:619059 OMIM:614388 OMIM:619847 ORPHA:348 OMIM:615471 OMIM:619991 OMIM:619147 ORPHA:298 OMIM:617668 OMIM:615838 OMIM:618329 OMIM:617228 OMIM:614582 OMIM:618378 OMIM:617950 OMIM:614702 ORPHA:927 OMIM:618249 OMIM:619003 OMIM:619170 OMIM:252010 OMIM:619386 OMIM:615273 OMIM:266150 OMIM:312170 OMIM:245349 ORPHA:79246 OMIM:251950 OMIM:619048 ORPHA:247598 OMIM:615418 ORPHA:470 OMIM:615918 OMIM:618250 OMIM:614052 OMIM:616974 OMIM:615160 OMIM:615917
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.